Race Oncology Limited (RAC.AX)

AUD 1.33

(-3.64%)

Operating Expenses Summary of Race Oncology Limited

  • Race Oncology Limited's latest annual operating expenses in 2024 was 14.77 Million AUD , up 16.25% from previous year.
  • Race Oncology Limited's latest quarterly operating expenses in 2024 FY was 17.55 Million AUD , up 38.13% from previous quarter.
  • Race Oncology Limited reported a annual operating expenses of 12.7 Million AUD in annual operating expenses 2023, up 13.4% from previous year.
  • Race Oncology Limited reported a annual operating expenses of 11.2 Million AUD in annual operating expenses 2022, up 80.87% from previous year.
  • Race Oncology Limited reported a quarterly operating expenses of 7.19 Million AUD for 2024 Q4, down 0.0% from previous quarter.
  • Race Oncology Limited reported a quarterly operating expenses of 17.55 Million AUD for 2024 FY, up 38.13% from previous quarter.

Annual Operating Expenses Chart of Race Oncology Limited (2024 - 2013)

Historical Annual Operating Expenses of Race Oncology Limited (2024 - 2013)

Year Operating Expenses Operating Expenses Growth
2024 14.77 Million AUD 16.25%
2023 12.7 Million AUD 13.4%
2022 11.2 Million AUD 80.87%
2021 6.19 Million AUD 68.38%
2020 3.67 Million AUD 5.67%
2019 3.48 Million AUD -42.71%
2018 6.07 Million AUD 60.28%
2017 3.79 Million AUD 664.24%
2016 496.2 Thousand AUD 465.49%
2015 87.74 Thousand AUD -7.84%
2014 95.21 Thousand AUD 625.65%
2013 13.12 Thousand AUD 0.0%

Peer Operating Expenses Comparison of Race Oncology Limited

Name Operating Expenses Operating Expenses Difference
EZZ Life Science Holdings Limited 39.57 Million AUD 62.677%
Anatara Lifesciences Ltd 710.21 Thousand AUD -1979.713%
Zelira Therapeutics Limited 5.94 Million AUD -148.305%
Biome Australia Limited 7.91 Million AUD -86.703%
Patrys Limited 4.93 Million AUD -199.403%
Orthocell Limited 15.36 Million AUD 3.898%
Imugene Limited 135.09 Million AUD 89.066%
Noxopharm Limited 7 Million AUD -111.001%
PYC Therapeutics Limited 60.91 Million AUD 75.753%
Chimeric Therapeutics Limited 19.76 Million AUD 25.278%
Prescient Therapeutics Limited 10.89 Million AUD -35.524%
Proteomics International Laboratories Limited 892.14 Thousand AUD -1555.617%
Cynata Therapeutics Limited 11.12 Million AUD -32.785%
CSL Limited 7.56 Billion AUD 99.805%
Arovella Therapeutics Limited 10.78 Million AUD -36.95%
Bio-Gene Technology Limited 2.76 Million AUD -434.966%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 52.806%
Starpharma Holdings Limited 22.81 Million AUD 35.263%
Nanollose Limited 12.5 Thousand AUD -118054.34%
Memphasys Limited 3.67 Million AUD -301.548%
Invex Therapeutics Ltd 3.34 Million AUD -341.452%
NeuroScientific Biopharmaceuticals Limited 1.96 Million AUD -651.594%
Amplia Therapeutics Limited 8.43 Million AUD -75.094%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -2354.301%
Island Pharmaceuticals Limited 4.12 Million AUD -258.041%
Nyrada Inc. 4.55 Million AUD -224.258%
Telix Pharmaceuticals Limited 269.26 Million AUD 94.515%
Dimerix Limited 25.64 Million AUD 42.4%
PharmAust Limited 6.65 Million AUD -121.879%
Immutep Limited 42.87 Million AUD 65.55%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 73.768%
Alterity Therapeutics Limited 23.4 Million AUD 36.896%
BTC Health Limited -1.03 Million AUD 1521.705%
Acrux Limited 8.55 Million AUD -72.754%
Neuren Pharmaceuticals Limited 32.69 Million AUD 54.826%
Biotron Limited 5.11 Million AUD -189.012%
Tissue Repair Ltd 6.66 Million AUD -121.552%
AdAlta Limited 6.76 Million AUD -118.191%
Radiopharm Theranostics Limited 299.22 Thousand AUD -4836.194%
Hexima Limited 1 Million AUD -1364.235%
AnteoTech Limited 12.18 Million AUD -21.199%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 77.312%
Recce Pharmaceuticals Ltd 21.68 Million AUD 31.885%
Avecho Biotechnology Limited 4.54 Million AUD -224.955%
Actinogen Medical Limited 22.77 Million AUD 35.133%
Immuron Limited 9.13 Million AUD -61.639%
Argenica Therapeutics Limited 8.26 Million AUD -78.622%